{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:33:28Z","timestamp":1791250408400,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Norwegian Institute of Public Health"},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00125-018-4662-7","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T10:35:38Z","timestamp":1529663738000},"page":"1996-2004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3404-2060","authenticated-orcid":false,"given":"Paz L. D.","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger J.","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri E.","family":"H\u00e5berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Hungnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne L.","family":"Gulseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars C.","family":"Stene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"4662_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/pedi.12370","volume":"17","author":"H Hy\u00f6ty","year":"2016","unstructured":"Hy\u00f6ty H (2016) Viruses in type 1 diabetes. Pediatr Diabetes 17:56\u201364","journal-title":"Pediatr Diabetes"},{"key":"4662_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrendo.2016.30","volume":"12","author":"A Beeck Op de","year":"2016","unstructured":"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus--why the beta cells? Nat Rev Endocrinol 12:263\u2013273","journal-title":"Nat Rev Endocrinol"},{"key":"4662_CR3","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.autrev.2016.07.019","volume":"15","author":"T Rodriguez-Calvo","year":"2016","unstructured":"Rodriguez-Calvo T, Sabouri S, Anquetil F, von Herrath MG (2016) The viral paradigm in type 1 diabetes: who are the main suspects? Autoimmun Rev 15:964\u2013969","journal-title":"Autoimmun Rev"},{"key":"4662_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamapediatrics.2013.158","volume":"167","author":"A Beyerlein","year":"2013","unstructured":"Beyerlein A, Wehweck F, Ziegler A-G, Pflueger M (2013) Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study. JAMA Pediatr 167:800\u2013807","journal-title":"JAMA Pediatr"},{"key":"4662_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/dmrr.1258","volume":"27","author":"T Rasmussen","year":"2011","unstructured":"Rasmussen T, Wits\u00f8 E, Tapia G, Stene LC, R\u00f8nningen KS (2011) Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study. Diabetes Metab Res Rev 27:834\u2013837","journal-title":"Diabetes Metab Res Rev"},{"key":"4662_CR6","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1001\/jama.2016.2181","volume":"315","author":"A Beyerlein","year":"2016","unstructured":"Beyerlein A, Donnachie E, Jergens S, Ziegler A (2016) Infections in early life and development of type 1 diabetes. JAMA 315:1899\u20131901","journal-title":"JAMA"},{"key":"4662_CR7","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00125-017-4365-5","volume":"60","author":"M Lonnrot","year":"2017","unstructured":"Lonnrot M, Lynch KF, Elding Larsson H et al (2017) Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia 60:1931\u20131940","journal-title":"Diabetologia"},{"key":"4662_CR8","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/eurpub\/ckv059","volume":"25","author":"H-Y Lee","year":"2015","unstructured":"Lee H-Y, Lu C-L, Chen H-F, Su H-F, Li C-Y (2015) Perinatal and childhood risk factors for early-onset type 1 diabetes: a population-based case-control study in Taiwan. Eur J Pub Health 25:1024\u20131029","journal-title":"Eur J Pub Health"},{"key":"4662_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1128\/JVI.00714-12","volume":"87","author":"I Capua","year":"2013","unstructured":"Capua I, Mercalli A, Pizzuto MS et al (2013) Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model. J Virol 87:597\u2013610","journal-title":"J Virol"},{"key":"4662_CR10","first-page":"640","volume":"12","author":"A Blum","year":"2010","unstructured":"Blum A, Podvitzky O, Shalabi R, Simsolo C (2010) Acute pancreatitis may be caused by H1N1 influenza A virus infection. Isr Med Assoc J 12:640\u2013641","journal-title":"Isr Med Assoc J"},{"key":"4662_CR11","doi-asserted-by":"publisher","first-page":"1911.e1911","DOI":"10.1016\/j.ajem.2016.01.019","volume":"34","author":"A Habib","year":"2016","unstructured":"Habib A, Jain A, Singh B, Jamshed N (2016) H1N1 influenza presenting as severe acute pancreatitis and multiorgan dysfunction. Am J Emerg Med 34:1911.e1911\u20131911.e1912","journal-title":"Am J Emerg Med"},{"key":"4662_CR12","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.clinre.2012.01.002","volume":"36","author":"B Baran","year":"2012","unstructured":"Baran B, Karaca C, Soyer OM et al (2012) Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: a case report. Clin Res Hepatol Gastroenterol 36:e69\u2013e70","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4662_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1753-0407.2010.00110.x","volume":"3","author":"N Watanabe","year":"2011","unstructured":"Watanabe N (2011) Conversion to type 1 diabetes after H1N1 influenza infection: a case report. J Diabetes 3:103","journal-title":"J Diabetes"},{"key":"4662_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/adc.2009.176859","volume":"96","author":"PJ Larcombe","year":"2011","unstructured":"Larcombe PJ, Moloney SE, Schmidt PA (2011) Pandemic (H1N1) 2009: a clinical spectrum in the general paediatric population. Arch Dis Child 96:96\u201398","journal-title":"Arch Dis Child"},{"key":"4662_CR15","unstructured":"World Health Organization (2014) Influenza virus infections in humans [Internet]. Available from http:\/\/www.who.int\/influenza\/human_animal_interface\/virology_laboratories_and_vaccines\/influenza_virus_infections_humans_feb14.pdf?ua=1 . Accessed 9 Oct 2017"},{"key":"4662_CR16","unstructured":"DG Statement following the meeting of the Emergency Committee, WHO Available from http:\/\/www.who.int\/csr\/disease\/swineflu\/4th_meeting_ihr\/en\/ . Accessed 9 Oct 2017"},{"key":"4662_CR17","first-page":"161","volume":"11","author":"C Valdes","year":"2013","unstructured":"Valdes C, Unanue N, Hernandez M et al (2013) Is there a link between influenza and type I diabetes? Increased incidence of TID during the pandemic H1N1 influenza of 2009 in Chile. Pediatr Endocrinol Rev 11:161\u2013166","journal-title":"Pediatr Endocrinol Rev"},{"key":"4662_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/039463201102400311","volume":"24","author":"R Nenna","year":"2011","unstructured":"Nenna R, Papoff P, Moretti C et al (2011) Detection of respiratory viruses in the 2009 winter season in Rome: 2009 influenza A (H1N1) complications in children and concomitant type 1 diabetes onset. Int J Immunopathol Pharmacol 24:651\u2013659","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4662_CR19","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309:2473\u20132479","journal-title":"JAMA"},{"key":"4662_CR20","doi-asserted-by":"publisher","first-page":"e6-e8","DOI":"10.1097\/EDE.0000000000000748","volume":"29","author":"PLD Ruiz","year":"2018","unstructured":"Ruiz PLD, Stene LC, Gulseth HL et al (2018) Pandemic influenza A H1N1 vaccination and subsequent risk of type 1 diabetes in Norway. Epidemiology 29:e6-e8","journal-title":"Epidemiology"},{"key":"4662_CR21","doi-asserted-by":"publisher","first-page":"e0151575","DOI":"10.1371\/journal.pone.0151575","volume":"11","author":"T Effelterre Van","year":"2016","unstructured":"Van Effelterre T, Dos Santos G, Shinde V (2016) Twin peaks: A\/H1N1 pandemic influenza virus infection and vaccination in Norway, 2009\u20132010. PLoS One 11:e0151575","journal-title":"PLoS One"},{"key":"4662_CR22","doi-asserted-by":"publisher","first-page":"e30018","DOI":"10.1371\/journal.pone.0030018","volume":"7","author":"B Freiesleben de Blasio","year":"2012","unstructured":"Freiesleben de Blasio B, Iversen BG, Scalia Tomba G, Barry MA (2012) Effect of vaccines and antivirals during the major 2009 A (H1N1) pandemic wave in Norway--and the influence of vaccination timing. PLoS One 7:e30018","journal-title":"PLoS One"},{"key":"4662_CR23","doi-asserted-by":"crossref","unstructured":"Trogstad L, Ung G, Hagerup-Jenssen M, Cappelen I, Haugen IL, Feiring B (2012) The Norwegian immunisation register\u2014SYSVAK. Euro Surveill 17:pii:20147","DOI":"10.2807\/ese.17.16.20147-en"},{"key":"4662_CR24","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.mehy.2011.09.021","volume":"77","author":"G Anestad","year":"2011","unstructured":"Anestad G, Nordbo SA (2011) Virus interference. Did rhinoviruses activity hamper the progress of the 2009 influenza A (H1N1) pandemic in Norway? Med Hypotheses 77:1132\u20131134","journal-title":"Med Hypotheses"},{"key":"4662_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa1207210","volume":"368","author":"SE H\u00e5berg","year":"2013","unstructured":"H\u00e5berg SE, Trogstad L, Gunnes N et al (2013) Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 368:333\u2013340","journal-title":"N Engl J Med"},{"key":"4662_CR26","doi-asserted-by":"publisher","unstructured":"Furu K (2008) Establishment of the nationwide Norwegian Prescription Database (NorPD)\u2014new opportunities for research in pharmacoepidemiology in Norway. Norsk Epidemiologi 18 https:\/\/doi.org\/10.5324\/nje.v18i2.23","DOI":"10.5324\/nje.v18i2.23"},{"key":"4662_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00125-013-3090-y","volume":"57","author":"T Skrivarhaug","year":"2014","unstructured":"Skrivarhaug T, Stene LC, Drivvoll AK, Str\u00f8m H, Joner G, Group NCDS (2014) Incidence of type 1 diabetes in Norway among children aged 0\u201314 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia 57:57\u201362","journal-title":"Diabetologia"},{"key":"4662_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/fampra\/cmr064","volume":"29","author":"KA Simonsen","year":"2012","unstructured":"Simonsen KA, Hunskaar S, Wensaas K-A et al (2012) Influenza-like illness in Norway: clinical course, attitudes towards vaccination and preventive measures during the 2009 pandemic. Fam Pract 29:139\u2013146","journal-title":"Fam Pract"},{"key":"4662_CR29","doi-asserted-by":"publisher","first-page":"e69408","DOI":"10.1371\/journal.pone.0069408","volume":"8","author":"KA Simonsen","year":"2013","unstructured":"Simonsen KA, Hunskaar S, Sandvik H, Rortveit G (2013) Capacity and adaptations of general practice during an influenza pandemic. PLoS One 8:e69408","journal-title":"PLoS One"},{"key":"4662_CR30","unstructured":"Swedish WHO National Influenza Centre (2011) The influenza A(H1N1)2009 pandemic in Sweden, 2009\u20132010. Available from https:\/\/www.folkhalsomyndigheten.se\/pagefiles\/15030\/influenza-in-sweden-2009-2010.pdf . Accessed 9 Oct 2017"},{"key":"4662_CR31","unstructured":"(2010) Rapport. Ny influensa A (H1N1) 2009. Gjennomgang av erfaringene i Norge. Direktoratet for samfunnssikkerhet og beredskap (DSB), Oslo [In Norwegian]. Available from http:\/\/www.dsbinfo.no\/DSBno\/2010\/Rapport\/Pandemirapport\/ . Accessed 9 Oct 2017"},{"key":"4662_CR32","doi-asserted-by":"crossref","first-page":"19633","DOI":"10.2807\/ese.15.31.19633-en","volume":"15","author":"K Waalen","year":"2010","unstructured":"Waalen K, Kilander A, Dudman S, Krogh G, Aune T, Hungnes O (2010) High prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 15:19633","journal-title":"Euro Surveill"},{"key":"4662_CR33","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1007\/s00125-015-3723-4","volume":"58","author":"A Kondrashova","year":"2015","unstructured":"Kondrashova A, Nurminen N, Patrikainen M et al (2015) Influenza A virus antibodies show no association with pancreatic islet autoantibodies in children genetically predisposed to type 1 diabetes. Diabetologia 58:2592\u20132595","journal-title":"Diabetologia"},{"key":"4662_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/BOR.0b013e3283533719","volume":"24","author":"U Christen","year":"2012","unstructured":"Christen U, Bender C, von Herrath MG (2012) Infection as a cause of type 1 diabetes? Curr Opin Rheumatol 24:417","journal-title":"Curr Opin Rheumatol"},{"key":"4662_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1399-5448.2006.00198.x","volume":"7","author":"LC Stene","year":"2006","unstructured":"Stene LC, Barriga K, Hoffman M et al (2006) Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes 7:247\u2013253","journal-title":"Pediatr Diabetes"},{"key":"4662_CR36","doi-asserted-by":"publisher","unstructured":"Cuesta JG, Aavitsland P, Englund H et al (2016) Pandemic vaccination strategies and influenza severe outcomes during the influenza A (H1N1) pdm09 pandemic and the post-pandemic influenza season: the Nordic experience. Euro Surveill 21 https:\/\/doi.org\/10.2807\/1560-7917.ES.2016.21.16.30208","DOI":"10.2807\/1560-7917.ES.2016.21.16.30208"},{"key":"4662_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/jdi.12690","volume":"9","author":"Z Qi","year":"2018","unstructured":"Qi Z, Hu H, Wang Z et al (2018) Antibodies against H1N1 influenza virus cross-react with alpha-cells of pancreatic islets. J Diabetes Investig 9:265\u2013269","journal-title":"J Diabetes Investig"},{"key":"4662_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nm.2262","volume":"17","author":"AC Monsalvo","year":"2011","unstructured":"Monsalvo AC, Batalle JP, Lopez MF et al (2011) Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 17:195\u2013199","journal-title":"Nat Med"},{"key":"4662_CR39","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.2337\/db14-0510","volume":"63","author":"SJ Richardson","year":"2014","unstructured":"Richardson SJ, Horwitz MS (2014) Is type 1 diabetes \u201cgoing viral\u201d? Diabetes 63:2203\u20132205","journal-title":"Diabetes"},{"key":"4662_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00125-017-4448-3","volume":"61","author":"H Elding Larsson","year":"2018","unstructured":"Elding Larsson H, Lynch KF, Lonnrot M et al (2018) Pandemrix(R) vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Diabetologia 61:193\u2013202","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4662-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4662-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4662-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T04:58:08Z","timestamp":1661489888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4662-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4662"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4662-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HLG has received grants for lectures or consulting from AstraZeneca, Novo Nordisk, Sanofi, Boehringer Ingelheim and Merck Sharp & Dohme. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}